A prospective, randomized, controlled study to compare two doses of recombinant human chorionic gonadotropin in serum and follicular fluid in woman with high body mass index

This prospective, randomized, controlled study compares the efficiency of 250 μg or 500 μg of recombinant hCG in serum and follicular fluid (FF) levels and pregnancy rates (PR) in women with high body mass index (BMI) (≥26 kg/m2) undergoing assisted reproduction treatment (ART). Treatment outcomes are similar between the two groups.